It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...

Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of Directors Pharmaceutical Research and Manufacturers of America (PhRMA) Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of ...

Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's drug pipeline, vaccines and more. Former Vice President Kamala Harris ...

An icon in the shape of a lightning bolt. Impact Link Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT's Flaws. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the ...

(Image Credits: Reuters) Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the United States. The plan comes as the Trump ...

In his previous comments about Pfizer Inc. (NYSE:PFE), Cramer has remained optimistic about the firm’s CEO Dr. Bourla. This time around, he shared how the company is using AI in its operations ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...